v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

UNDIAGNOSED DIABETES MELLITUS IN ACUTE CORONARY SYNDROME (ACS) PATIENTS

AUTHORS:

Sana Maqsood, Sidra Arif, Misbah Shakoor

ABSTRACT:

Introduction: One of the main risk factors leading to coronary artery disease (CAD) is diabetes mellitus. Type 2 diabetes prove to be an important cause of cardiovascular morbidity and mortality in patients admitted for suspected myocardial infarction. Diabetes mellitus is associated with worse prognosis in hospitalized patients with CAD. Objective: To determine the frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome in a tertiary care hospital in Faisalabad. Materials and Methods Study design: Cross sectional study Setting: Department of Cardiology, Allied hospital, Faisalabad Duration: Six months (09-2018 to 03-2019) Data collection procedure: Total 140 patients meeting the inclusion and exclusion criteria were included in the study. Relevant data according to the predesigned questionnaire including age, gender, ACS category (STEMI, Non-STEMI or unstable angina) was recorded. For diagnosis of diabetes, 3 cc serum blood sample was taken for fasting blood sugar and HbA1c. Undiagnosed diabetes mellitus was recorded. Results: There were 110(78.6%) males and 30(21.4%) females in our study. The mean age of patients was 57.08±12.72 years. The mean height was 171.95±14.37 cm, mean weight was 80.70±11.23 kg and mean BMI was 26.89±3.64. There were 63(45%) patients with family history of diabetes. There were 60(42.9%) patients with Non-STEMI, 52(37.1%) with STEMI and 28(20%) with unstable angina. The mean HbA1c of the patients was 6.11±0.86. There were 10(7.1%) patients with undiagnosed Diabetes mellitus. Conclusion: The frequency of undiagnosed diabetes mellitus in patients with ACS was 7.1%. Key words: Undiagnosed Diabetes Mellitus, Acute Coronary Syndrome, type 2 diabetes, family history, STEMI,

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.